Russell RGG - Search Results

1

Differences in intracellular localisation of ANKH mutants that relate to mechanisms of calcium pyrophosphate deposition disease and craniometaphyseal dysplasia.

Vijen S, Hawes C, Runions J, Russell RGG, Wordsworth BP, Carr AJ, Pink RC, Zhang Y. Vijen S, et al. Among authors: russell rgg. Sci Rep. 2020 May 4;10(1):7408. doi: 10.1038/s41598-020-63911-x. Sci Rep. 2020. PMID: 32366894 Free PMC article.

2

Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.

Williams CJ, Zhang Y, Timms A, Bonavita G, Caeiro F, Broxholme J, Cuthbertson J, Jones Y, Marchegiani R, Reginato A, Russell RG, Wordsworth BP, Carr AJ, Brown MA. Williams CJ, et al. Am J Hum Genet. 2002 Oct;71(4):985-91. doi: 10.1086/343053. Epub 2002 Sep 17. Am J Hum Genet. 2002. PMID: 12297989 Free PMC article.

3

Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5'-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate.

Zhang Y, Johnson K, Russell RG, Wordsworth BP, Carr AJ, Terkeltaub RA, Brown MA. Zhang Y, et al. Arthritis Rheum. 2005 Apr;52(4):1110-7. doi: 10.1002/art.20978. Arthritis Rheum. 2005. PMID: 15818664 Free article.

4

Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients.

Petrie KA, Lee WH, Bullock AN, Pointon JJ, Smith R, Russell RG, Brown MA, Wordsworth BP, Triffitt JT. Petrie KA, et al. PLoS One. 2009;4(3):e5005. doi: 10.1371/journal.pone.0005005. Epub 2009 Mar 30. PLoS One. 2009. PMID: 19330033 Free PMC article.

5

Advances in the molecular pharmacology of bone and cancer-related bone diseases.

Edwards CM, Russell RGG. Edwards CM, et al. Among authors: russell rgg. Br J Pharmacol. 2021 May;178(9):1889-1890. doi: 10.1111/bph.15431. Br J Pharmacol. 2021. PMID: 33860527 Free article. No abstract available.

6

The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants.

Tsoumpra MK, Muniz JR, Barnett BL, Kwaasi AA, Pilka ES, Kavanagh KL, Evdokimov A, Walter RL, Von Delft F, Ebetino FH, Oppermann U, Russell RGG, Dunford JE. Tsoumpra MK, et al. Among authors: russell rgg. Bone. 2015 Dec;81:478-486. doi: 10.1016/j.bone.2015.08.020. Epub 2015 Aug 28. Bone. 2015. PMID: 26318908 Free PMC article.

7

Hypophosphatasia: biochemical screening of a Dutch kindred and evidence that urinary excretion of inorganic pyrophosphate is a marker for the disease.

Macfarlane JD, Poorthuis BJ, van de Kamp JJ, Russell RG, Caswell AM. Macfarlane JD, et al. Clin Chem. 1988 Sep;34(9):1937-41. Clin Chem. 1988. PMID: 2843309

8

Bisphosphonates: the first 40 years.

Russell RG. Russell RG. Bone. 2011 Jul;49(1):2-19. doi: 10.1016/j.bone.2011.04.022. Epub 2011 May 1. Bone. 2011. PMID: 21555003 Review.

9

Editorial overview: Musculoskeletal: Are there common targets to prevent age-related changes in muscle, cartilage and bone?

Gallagher JA, Russell RG. Gallagher JA, et al. Curr Opin Pharmacol. 2015 Jun;22:v-viii. doi: 10.1016/j.coph.2015.05.007. Epub 2015 May 29. Curr Opin Pharmacol. 2015. PMID: 26031883 No abstract available.

10

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.

Pazianas M, Cooper C, Ebetino FH, Russell RG. Pazianas M, et al. Ther Clin Risk Manag. 2010 Jul 21;6:325-43. doi: 10.2147/tcrm.s8054. Ther Clin Risk Manag. 2010. PMID: 20668715 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page